PARIS (Reuters) -The French government needs guarantees from drugmaker Sanofi that production of its popular Doliprane ...

France's Economy and Industry ministers, Antoine Armand and Marc Ferracci, are heading to Lisieux this Monday to visit the ...

The French government is looking at options including state-owned investment bank BPIfrance taking a stake in the consumer ...

The French government is looking at options including taking a state holding in the consumer health business that Sanofi is ...

Recent health news highlights include HIV transmission via organ transplants in Brazil, Sanofi discussing a sale of its ...

GSK , Sanofi and CSL Ltd have secured $72 million from the U.S. government to ramp up production of bird flu vaccines, a ...

The planned sale of France's best-selling medical drug to US investors has caused the government a splitting headache after ...

The summary covers major health news, including six transplant patients in Brazil contracting HIV from infected organs, ...

Clayton Dubilier & Rice (CD&R) has entered negotiations to acquire a 50 percent controlling stake in Sanofi’s consumer healthcare business Opella.

Potential deal by Clayton Dubilier & Rice for a leading consumer healthcare business; Arlington Capital Partners’ Matthew ...

While Sanofi's list price of Aubagio is set at £13,529 ($22,100) per patient a year, NICE was able to recommend it for the NHS after Sanofi made the drug available at a discount under the patient ...

The Digital Markets, Competition and Consumers Act 2024 (UK DMCC) introduces significant reforms to the UK’s Competition and Markets Authority ...